Presentation TCT 2016

TCT 5: Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights From the ACUITY Trial

Presenter: Ramin Ebrahimi

October 31, 2016

REGISTER for free or LOG IN to view this content

TCT 5: Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights From the ACUITY Trial

Coronary

Presentation

TCT 2016

CAD Pharma

Up Next

Presentation TCT 2016

TCT 6: Simultaneous Impact of Thrombotic and Bleeding Risks on Use of Novel P2Y12 Inhibitors in Contemporary PCI: Results From a Large Single-Center Registry

Presenter: Usman Baber

October 31, 2016

More slides +

Presentation TCT 2016

TCT 7: Relationship Between Traditional Risk Factors, Platelet Reactivity, and Thrombotic Events: A Mediation Analysis From ADAPT-DES

Presenter: Bjorn Redfors

October 31, 2016

Presentation TCT 2016

TCT 606: Can we justify conservative treatment in adults with Anomalous Coronary Artery Originating from the Opposite Sinus of Valsalva (ACAOS) with Inter-Arterial Course (IAC)?

Presenter: Theodore A. Bass

October 31, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.